Literature DB >> 28556097

Diabetic macular oedema: clinical risk factors and emerging genetic influences.

Ebony Liu1, Jamie E Craig1, Kathryn Burdon2.   

Abstract

Diabetic macular oedema is the major cause of visual impairment in type 1 and type 2 diabetes. As type 2 diabetes becomes more prevalent worldwide, the prevalence of diabetic macular oedema is also expected to rise. Current management of diabetic macular oedema is challenging, expensive and not optimal in a subset of patients. Therefore, it is important to increase our understanding of the risk factors involved and develop preventative strategies. While clinical risk factors for diabetic macular oedema have been identified, few studies have addressed potential genetic risk factors. Epidemiology and family studies suggest genetic influences are of importance. In this review, we summarise known clinical risk factors, as well as discuss the small number of genetic studies that have been performed for diabetic macular oedema.
© 2017 Optometry Australia.

Entities:  

Keywords:  diabetes; retinopathy

Mesh:

Substances:

Year:  2017        PMID: 28556097     DOI: 10.1111/cxo.12552

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  6 in total

1.  Nomogram-based prediction of clinically significant macular edema in diabetes mellitus patients.

Authors:  Zijing Li; Xiaowen Deng; Lijun Zhou; Tu Lu; Yuqing Lan; Chenjin Jin
Journal:  Acta Diabetol       Date:  2022-06-24       Impact factor: 4.087

2.  Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus.

Authors:  Atsuki Kume; Kenji Kashiwagi
Journal:  BMC Ophthalmol       Date:  2020-07-29       Impact factor: 2.209

3.  The Diurnal Rhythm of Insulin Receptor Substrate-1 (IRS-1) and Kir4.1 in Diabetes: Implications for a Clock Gene Bmal1.

Authors:  Qianyi Luo; Yucheng Xiao; Alpha Alex; Theodore R Cummins; Ashay D Bhatwadekar
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

4.  Working Towards Eye Health Equity for Indigenous Australians with Diabetes.

Authors:  Jose J Estevez; Natasha J Howard; Jamie E Craig; Alex Brown
Journal:  Int J Environ Res Public Health       Date:  2019-12-12       Impact factor: 3.390

5.  Tofacitinib Ameliorates Retinal Vascular Leakage in a Murine Model of Diabetic Retinopathy with Type 2 Diabetes.

Authors:  Eimear M Byrne; María Llorián-Salvador; Timothy J Lyons; Mei Chen; Heping Xu
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

6.  Treatment of Diabetic Macular Edema with Intravitreal Antivascular Endothelial Growth Factor and Prompt versus Deferred Focal Laser during Long-Term Follow-Up and Identification of Prognostic Retinal Markers.

Authors:  Birgit Weingessel; Kata Miháltz; Andreas Gleiss; Florian Sulzbacher; Christopher Schütze; Pia V Vécsei-Marlovits
Journal:  J Ophthalmol       Date:  2018-10-01       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.